These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

450 related articles for article (PubMed ID: 35564876)

  • 1. Proposing a "Brain Health Checkup (BHC)" as a Global Potential "Standard of Care" to Overcome Reward Dysregulation in Primary Care Medicine: Coupling Genetic Risk Testing and Induction of "Dopamine Homeostasis".
    Braverman ER; Dennen CA; Gold MS; Bowirrat A; Gupta A; Baron D; Roy AK; Smith DE; Cadet JL; Blum K
    Int J Environ Res Public Health; 2022 Apr; 19(9):. PubMed ID: 35564876
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular neurological correlates of endorphinergic/dopaminergic mechanisms in reward circuitry linked to endorphinergic deficiency syndrome (EDS).
    Blum K; Baron D; McLaughlin T; Gold MS
    J Neurol Sci; 2020 Apr; 411():116733. PubMed ID: 32088516
    [TBL] [Abstract][Full Text] [Related]  

  • 3. How to Combat the Global Opioid Crisis.
    Dennen A C; Blum K; Braverman R E; Bowirrat A; Gold M; Elman I; Thanos K P; Baron D; Gupta A; Edwards D; Badgaiyan D R
    CPQ Neurol Psychol; 2023; 5(4):. PubMed ID: 36812107
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overcoming qEEG abnormalities and reward gene deficits during protracted abstinence in male psychostimulant and polydrug abusers utilizing putative dopamine D₂ agonist therapy: part 2.
    Blum K; Chen TJ; Morse S; Giordano J; Chen AL; Thompson J; Allen C; Smolen A; Lubar J; Stice E; Downs BW; Waite RL; Madigan MA; Kerner M; Fornari F; Braverman ER
    Postgrad Med; 2010 Nov; 122(6):214-26. PubMed ID: 21084796
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypothesizing dopaminergic genetic antecedents in schizophrenia and substance seeking behavior.
    Blum K; Oscar-Berman M; Badgaiyan RD; Palomo T; Gold MS
    Med Hypotheses; 2014 May; 82(5):606-14. PubMed ID: 24636783
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Why haven't we solved the addiction crisis?
    Blum K; Bowirrat A; Gomez LL; Downs BW; Bagchi D; Barh D; Modestino EJ; Baron D; McLaughlin T; Thanos P; Ceccanti M; Elman I; Badgaiyan RD; Dennen C; Gupta A; Braverman ER; Gold MS
    J Neurol Sci; 2022 Nov; 442():120404. PubMed ID: 36084363
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Review of DNA Risk Alleles to Determine Epigenetic Repair of mRNA Expression to Prove Therapeutic Effectiveness in Reward Deficiency Syndrome (RDS): Embracing "Precision Behavioral Management".
    Blum K; Steinberg B; Gondre-Lewis MC; Baron D; Modestino EJ; Badgaiyan RD; Downs BW; Bagchi D; Brewer R; McLaughlin T; Bowirrat A; Gold M
    Psychol Res Behav Manag; 2021; 14():2115-2134. PubMed ID: 34949945
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dopaminergic dysfunction: Role for genetic & epigenetic testing in the new psychiatry.
    Blum K; Ashford JW; Kateb B; Sipple D; Braverman E; Dennen CA; Baron D; Badgaiyan R; Elman I; Cadet JL; Thanos PK; Hanna C; Bowirrat A; Modestino EJ; Yamamoto V; Gupta A; McLaughlin T; Makale M; Gold MS
    J Neurol Sci; 2023 Oct; 453():120809. PubMed ID: 37774561
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuro-chemical activation of brain reward meso-limbic circuitry is associated with relapse prevention and drug hunger: a hypothesis.
    Blum K; Gold MS
    Med Hypotheses; 2011 Apr; 76(4):576-84. PubMed ID: 21306831
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute intravenous synaptamine complex variant KB220™ "normalizes" neurological dysregulation in patients during protracted abstinence from alcohol and opiates as observed using quantitative electroencephalographic and genetic analysis for reward polymorphisms: part 1, pilot study with 2 case reports.
    Miller DK; Bowirrat A; Manka M; Miller M; Stokes S; Manka D; Allen C; Gant C; Downs BW; Smolen A; Stevens E; Yeldandi S; Blum K
    Postgrad Med; 2010 Nov; 122(6):188-213. PubMed ID: 21084795
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Do dopaminergic gene polymorphisms affect mesolimbic reward activation of music listening response? Therapeutic impact on Reward Deficiency Syndrome (RDS).
    Blum K; Chen TJ; Chen AL; Madigan M; Downs BW; Waite RL; Braverman ER; Kerner M; Bowirrat A; Giordano J; Henshaw H; Gold MS
    Med Hypotheses; 2010 Mar; 74(3):513-20. PubMed ID: 19914781
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Should Reward Deficiency Syndrome (RDS) Be Considered an Umbrella Disorder for Mental Illness and Associated Genetic and Epigenetic Induced Dysregulation of Brain Reward Circuitry?
    Blum K; Dennen CA; Elman I; Bowirrat A; Thanos PK; Badgaiyan RD; Downs BW; Bagchi D; Baron D; Braverman ER; Gupta A; Green R; McLaughlin T; Barh D; Gold MS
    J Pers Med; 2022 Oct; 12(10):. PubMed ID: 36294858
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neurogenetics and clinical evidence for the putative activation of the brain reward circuitry by a neuroadaptagen: proposing an addiction candidate gene panel map.
    Chen TJ; Blum K; Chen AL; Bowirrat A; Downs WB; Madigan MA; Waite RL; Bailey JA; Kerner M; Yeldandi S; Majmundar N; Giordano J; Morse S; Miller D; Fornari F; Braverman ER
    J Psychoactive Drugs; 2011; 43(2):108-27. PubMed ID: 21858957
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reward deficiency syndrome: genetic aspects of behavioral disorders.
    Comings DE; Blum K
    Prog Brain Res; 2000; 126():325-41. PubMed ID: 11105655
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypodopaminergia and "Precision Behavioral Management" (PBM): It is a Generational Family Affair.
    Fried L; Modestino EJ; Siwicki D; Lott L; Thanos PK; Baron D; Badgaiyan RD; Ponce JV; Giordano J; Downs WB; Gondré-Lewis MC; Bruce S; Braverman ER; Boyett B; Blum K
    Curr Pharm Biotechnol; 2020; 21(6):528-541. PubMed ID: 31820688
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neurological correlates of brain reward circuitry linked to opioid use disorder (OUD): Do homo sapiens acquire or have a reward deficiency syndrome?
    Gold MS; Baron D; Bowirrat A; Blum K
    J Neurol Sci; 2020 Nov; 418():117137. PubMed ID: 32957037
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Should We Embrace the Incorporation of Genetically Guided "Dopamine Homeostasis" in the Treatment of Reward Deficiency Syndrome (RSD) as a Frontline Therapeutic Modality?
    Blum K; Raza A; Schultz T; Jalali R; Green R; Brewer R; Thanos PK; McLaughlin T; Baron D; Bowirrat A; Elman I; Downs BW; Bagchi D; Badgaiyan RD
    Acta Sci Neurol; 2021 Feb; 4(2):17-24. PubMed ID: 33681869
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Translational Molecular Approaches in Substance Abuse Research.
    Fulton SL; Maze I
    Handb Exp Pharmacol; 2020; 258():31-60. PubMed ID: 31628598
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Addressing cortex dysregulation in youth through brain health check coaching and prophylactic brain development.
    Blum K; Braverman ER; Gold MS; Dennen CA; Baron D; Thanos PK; Hanna C; Elman I; Gondre-Lewis MC; Ashford JW; Newberg A; Madigan MA; Jafari N; Zeine F; Sunder K; Giordano J; Barh D; Gupta A; Carney P; Bowirrat A; Badgaiyan RD
    INNOSC Theranostics Pharmacol Sci; 2024 Apr; 7(2):1472. PubMed ID: 38766548
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Mesolimbic Dopamine System in Chronic Pain and Associated Affective Comorbidities.
    Serafini RA; Pryce KD; Zachariou V
    Biol Psychiatry; 2020 Jan; 87(1):64-73. PubMed ID: 31806085
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.